|
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 6.05 | ACUITE B- | Reaffirmed | Issuer not co-operating* | - |
Bank Loan Ratings | 2.45 | - | ACUITE A4 | Reaffirmed | Issuer not co-operating* |
Total Outstanding | 8.50 | - | - |
Rating Rationale |
Acuité has reaffirmed the long term rating of ‘ACUITE B-‘ (read as ACUITE B minus) and short term rating of ‘ACUITE A4’ (read as ACUITE A four) on the Rs.8.50 Cr. bank facilities of Azine Healthcare Private Limited(AHPL). The rating continues to be flagged as “Issuer Not Cooperating” and is based on the best available information. |
About the Company |
Azine Health care Private Limited(AHPL). incorporated in 2002, is an Ahmedabad-based company promoted by Mr. Shyamsunder Nandkishore Agarwal and Mrs. Rekha Shyamsunder Agarwal. The company is engaged in manufacturing of pharma products such as tablets, capsules, ointments and injectable. The manufacturing units are located at Ahmedabad (Gujarat) and Baddi (Himachal Pradesh) with an installed capacity of 20,00,000 units of tablets, 40,000 units of syrups, 20,000 bottles of ointment and 1,00,000 units of ORS per day. |
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower: |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer / borrower failed to submit such information before the due date. |
Limitation regarding information availability: |
The rating is based on information available from sources other than the issuer/borrower (in the absence of information provided by the issuer/borrower). Acuité endeavored to gather information about the entity/industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit ratingis based. |
Rating Sensitivity |
"No information provided by the issuer / available for Acuite to comment upon." |
Liquidity Position |
"No information provided by the issuer / available for Acuite to comment upon." |
Outlook |
Not Applicable |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 23 (Actual) | FY 22 (Actual) |
Operating Income | Rs. Cr. | 26.82 | 36.70 |
PAT | Rs. Cr. | 0.08 | 0.13 |
PAT Margin | (%) | 0.31 | 0.35 |
Total Debt/Tangible Net Worth | Times | 3.02 | 2.58 |
PBDIT/Interest | Times | 1.59 | 1.68 |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on Complexity Levels of the Rated Instrument |
In order to inform the investors about complexity of instruments, Acuité has categorized such instruments in three levels: Simple, Complex and Highly Complex. Acuite’ s categorisation of the instruments across the three categories is based on factors like variability of the returns to the investors, uncertainty in cash flow patterns, number of counterparties and general understanding of the instrument by the market. It has to be understood that complexity is different from credit risk and even an instrument categorized as 'Simple' can carry high levels of risk. For more details, please refer Rating Criteria “Complexity Level Of Financial Instruments” on www.acuite.in. |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Contacts |
|
|
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |